Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression

Схожие документы

• High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
  по: Tian, Yu-Feng, et al.
  Опубликовано: (2017)
• Low thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancer
  по: Lin, Cheng-Yi, et al.
  Опубликовано: (2015)
• High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer
  по: Lin, Ching-Yih, et al.
  Опубликовано: (2017)
• Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy
  по: Lee, Yi-Ying, et al.
  Опубликовано: (2017)
• High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
  по: Ke, Te-Min, et al.
  Опубликовано: (2020)